Filing Details
- Accession Number:
- 0001179110-20-001467
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-11 19:01:24
- Reporting Period:
- 2020-02-07
- Accepted Time:
- 2020-02-11 19:01:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1716468 | M. Anthony Manning | C/O Momenta Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-07 | 750 | $0.00 | 6,193 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-10 | 224 | $31.50 | 5,969 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Acquisiton | 2020-02-07 | 45,000 | $0.00 | 45,000 | $0.00 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-02-07 | 90,000 | $0.00 | 90,000 | $31.87 |
| Common Stock | Restricted Stock Units | Disposition | 2020-02-07 | 750 | $0.00 | 750 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 45,000 | No | 4 | A | Direct | ||
| 90,000 | 2030-02-07 | No | 4 | A | Direct | |
| 3,000 | No | 4 | M | Direct |
Footnotes
- Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017.
- Restricted Stock Units convert into common stock on a one-for-one basis.
- Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- Represents options granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated.
- Subject to certain criteria, the stock option will vest and become exercisable with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
Billionaire Hedge Funds
